OncLive® On Air Language: en Genres: Health & Fitness, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it Get all podcast data

Listen Now...

S12 Ep10: Olverembatinib Research Signals a New Era of CP-CML Management: With Elias Jabbour, MD
Episode 10
Monday, 3 February, 2025

In today’s episode, supported by Ascentage Pharma, we had the pleasure of speaking with Elias Jabbour, MD, a professor in the Department of Leukemia in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston. In our exclusive interview, Dr Jabbour discussed the 1.5-year follow-up data from a phase 1b trial (NCT04260022) investigating olverembatinib (HQP1351) in patients with heavily pretreated chronic-phase chronic myeloid leukemia (CML), enrollment considerations for the registrational phase 3 POLARIS-2 trial (NCT06423911) that is further evaluating the agent in this population, and potential future research directions in CML.

We also recommend:

The Volcano on Campus

The Big Bang - for iBooks
The Open University

BirdTalk Radio Podcast
BirdTalk Radio

HiRISE: The BeautifulMars Podcast (Audio)
HiRISE/UArizona

The New Product Launchpad (Video)
PLUGHITZ Live

NMO and The Power of Rare
The Guthy-Jackson Charitable Foundation

2nd Act Podcast
2nd Act Podcast

RadioLacan.com | I Forum Latino en Red - Zadig La movida Latina: Migraciones y después... en la NEL.

Detective de cosméticos

Who Would Win: cuttlefish vs vampire squid
Marcy

BigFoot Live Radio Show
Archive

Looking Up with Don
Don Machholz